Inventor · disambiguated record
Francine Jotereau
Also filed as: JOTEREAU FRANCINE
7 granted patents·3 pending applications·24 citations·filing 1995–2021
78Inventor score
Top patents by PatentIndex Score
10 records- 0171US5821122AIsolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereofLUDWIG INST CANCER RES·Filed 1995·Granted Oct 13, 1998·17 cites·16 claims
- 0264US8481477B2Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumorsGODEFROY EMMANUELLE·Filed 2011·Granted Jul 9, 2013·1 cites·11 claims
- 0358US9395368B2Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumorsGODEFROY EMMANUELLE·Filed 2013·Granted Jul 19, 2016·0 cites·11 claims
- 0452US7629439B2Peptides derived from the protein MMP-2, and the use thereof in antitumoral immunotherapyINST NAT SANTE RECH MED·Filed 2004·Granted Dec 8, 2009·0 cites·3 claims
- 0548US5886145AIsolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereofINST NAT SANTE RECH MED·Filed 1997·Granted Mar 23, 1999·6 cites·6 claims
- 0646US2006122119A1Peptides for use in antitumor immunotherapyUNIV NANTES·Filed 2003·Application pending·0 cites
- 0746US2024019437A1Methods for the diagnosis and the treatment of graft-versus-host diseaseINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0842US12405267B2Diagnosis, prognosis and treatment of a disease related to a decrease of F. prausnitziiINST NAT SANTE RECH MED·Filed 2019·Granted Sep 2, 2025·0 cites·3 claims
- 0940US2009081226A1Soluble HLA-E Molecules And Their Use For Diagnosing And Treating PathologiesINST NAT SANTE RECH MED·Filed 2005·Application pending·0 cites
- 1030US5958711AMethods for determining expression of NAG tumor rejection antigen precursorINST NAT SANTE RECH MED·Filed 1998·Granted Sep 28, 1999·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Francine Jotereau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →